MD Anderson
Bayer and MD Anderson collaborate on novel targeted cancer treatments
Linda Banks
Bayer, cancer partnership, cancer research, Innovation, MD Anderson, novel targeted cancer treatments
0 Comment
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
X
Bayer and MD Anderson collaborate on novel targeted cancer treatments
https://pharmaphorum.com/news/bayer-md-anderson-novel-targeted-cancer-treatments/
News/ News/ Oncology/ Top stories/ UK & Europe
Natural killer cells ‘a hundred times cheaper’ than CAR-T
Richard Staines
blood cancer, cancer, CAR T, cell therapy, MD Anderson
0 Comment
X
Natural killer cells ‘a hundred times cheaper’ than CAR-T
https://pharmaphorum.com/news/natural-killer-cancer-therapy-a-hundred-times-cheaper-than-car-t/